Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK—HER2 and VEGFR2 receptors, by in silico approach
dc.contributor.author | Paul, D. | |
dc.contributor.author | Mahanta, S. | |
dc.contributor.author | Tag, H. | |
dc.contributor.author | Jambhulkar, S. | |
dc.date.accessioned | 2024-11-21T04:39:46Z | |
dc.date.available | 2024-11-21T04:39:46Z | |
dc.date.issued | 2022 | |
dc.description.division | NA&BTD | en |
dc.format.extent | 6131 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Molecular Diversity, 2022. Vol. 26: pp. 1933-1955 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/27735 | |
dc.language.iso | en | en |
dc.subject | Panax sp. | en |
dc.subject | TKI | en |
dc.subject | HPLC/GC–MS/LC–MS | en |
dc.subject | HER2/VEGFR2 | en |
dc.subject | Breast cancer | en |
dc.subject | Stomach cancer | en |
dc.subject | Molecular docking | en |
dc.subject | MD simulations | en |
dc.subject | ADME-Tox | en |
dc.title | Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK—HER2 and VEGFR2 receptors, by in silico approach | en |
dc.type | Article | en |